Peroxisomal alterations in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
In Alzheimer's disease (AD), lipid alterations are present early during disease progression. As some of these alterations point towards a peroxisomal dysfunction, we investigated peroxisomes in human postmortem brains obtained from the cohort-based, longitudinal Vienna-Transdanube Aging (VITA) study. Based on the neuropathological Braak staging for AD on one hemisphere, the patients were grouped into three cohorts of increasing severity (stages I-II, III-IV, and V-VI, respectively). Lipid analyses of cortical regions from the other hemisphere revealed accumulation of C22:0 and very long-chain fatty acids (VLCFA, C24:0 and C26:0), all substrates for peroxisomal β-oxidation, in cases with stages V-VI pathology compared with those modestly affected (stages I-II). Conversely, the level of plasmalogens, which need intact peroxisomes for their biosynthesis, was decreased in severely affected tissues, in agreement with a peroxisomal dysfunction. In addition, the peroxisomal volume density was increased in the soma of neurons in gyrus frontalis at advanced AD stages. Confocal laser microscopy demonstrated a loss of peroxisomes in neuronal processes with abnormally phosphorylated tau protein, implicating impaired trafficking as the cause of altered peroxisomal distribution. Besides the original Braak staging, the study design allowed a direct correlation between the biochemical findings and the amount of neurofibrillary tangles (NFT) and neuritic plaques, quantified in adjacent tissue sections. Interestingly, the decrease in plasmalogens and the increase in VLCFA and peroxisomal volume density in neuronal somata all showed a stronger association with NFT than with neuritic plaques. These results indicate substantial peroxisome-related alterations in AD, which may contribute to the progression of AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PEX7 regulates peroxisomal protein import, and peroxisomes are abundant in dendrites (Kou et al., 2011).”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Kou et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Kou et al. [127] evidenced heterogeneity in the peroxisomal distribution in neurons of patients with AD, which was concentrated in the soma and absent in the dendrites”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [127]
Experimental — accuracy not yet measuredIn the citing paper
“implying that Tau does not allow the correct transit of these organelles, being an abnormally phosphorylated cytoskeleton protein, the possible cause of the increase in the oxidizing environment.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · cited 1×
“For improved method for analysis of plasmalogen subspecies, lipid standards dissolved in chloroform/methanol (1:2, vol/vol) were added to the extraction solvent before neutral lipid extraction, which was performed according to the method of Bligh and Dyer [5].”
MethodNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 3×
“The staging of AD-related neuropathology was done on the left brain hemisphere according to Braak and Braak [7, 8].”
BackgroundMethodMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 2×
“Agebased metabolic changes may lead to an imbalance of metabolites and/or second messengers promoting mitochondrial, endosomal–lysosomal and peroxisomal dysfunctions, which might be involved in the initiation of neuropathological events in AD [26, 32].”
BackgroundStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 3×
“The staging of AD-related neuropathology was done on the left brain hemisphere according to Braak and Braak [7, 8].”
MethodNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · cited 1×
“Although amyloid b plaques represent a hallmark of AD, NFT pathology is widely considered to correlate better with disease progression [2, 8].”
BackgroundSystematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“So far, the e4 allele of apolipoprotein E (APOE) is the best established genetic risk factor for sporadic AD [4, 39].”
BackgroundExtension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724 · cited 1×
“The observation that the life span of mice is extended when catalase, normally localized to the cytosol and to peroxisomes, is transgenically targeted to mitochondria supports the theory of organellar contribution to aging [37].”
BackgroundConsumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135 · cited 1×
“DHA incorporated into phospholipids and cholesterol esters were found to be reduced in brain [29] and plasma [12] of AD patients and several studies indicate a decreased risk for AD after an x3 (in particular DHA) rich diet [3, 20, 31].”
BackgroundBiochemistry of mammalian peroxisomes revisited
Wanders, R. J. A., & Waterham, H. R. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133329 · Cited by 995 · cited 6×
“In case of a generalized peroxisome deficiency, such as in patients affected by Zellweger spectrum disorder (ZSD), the loss of peroxisomal functions such as plasmalogen biosynthesis and fatty acid a and b-oxidation leads to decreased amounts of plasmalogens and bile acids, whereas very long-chain fatty acids (VLCFA),…”
BackgroundInfluentialSelf-citationDietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895 · cited 1×
“DHA incorporated into phospholipids and cholesterol esters were found to be reduced in brain [29] and plasma [12] of AD patients and several studies indicate a decreased risk for AD after an x3 (in particular DHA) rich diet [3, 20, 31].”
BackgroundStamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885 · cited 2×
“Previous observations in cultured neurons demonstrated that overexpression of tau inhibits kinesin-dependent transport of peroxisomes in neurites [28, 38].”
BackgroundPeroxisomes and oxidative stress
Schrader, M., & Fahimi, H. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.09.006 · Cited by 838 · cited 2×
“Peroxisomes are present in all nucleated human cells, including all cell types of the brain, and perform anabolic and catabolic functions and play a major role in generation and decomposition of ROS, reviewed in [1, 6, 36, 41].”
BackgroundThe pathological process underlying Alzheimer’s disease in individuals under thirty
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812 · cited 1×
“Although neurofibrillary degeneration may appear early in life [9], aging is one major factor for the development of AD-related neuropathology.”
BackgroundDocosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N., Ashe, K. H., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.013 · Cited by 707 · cited 10×
“2a) predominantly contains unsaturated or monounsaturated fatty acids, whereas in neurons PUFAs such as DHA and arachidonic acid dominate.”
BackgroundInfluentialHan, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 571 · cited 3×
“both gray and white matter of AD patients [15, 18, 19, 34].”
BackgroundResultConquer, J. A., Tierney, M. C., Zecevic, J., Bettger, W. J., & Fisher, R. H. (2000) · Lipids · doi:10.1007/s11745-000-0646-3 · Cited by 524 · cited 1×
“DHA incorporated into phospholipids and cholesterol esters were found to be reduced in brain [29] and plasma [12] of AD patients and several studies indicate a decreased risk for AD after an x3 (in particular DHA) rich diet [3, 20, 31].”
BackgroundFish, meat, and risk of dementia: cohort study
Barberger-Gateau, P. (2002) · BMJ · doi:10.1136/bmj.325.7370.932 · Cited by 486
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses
Mandelkow, E. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.007 · Cited by 401 · cited 2×
“Previous observations in cultured neurons demonstrated that overexpression of tau inhibits kinesin-dependent transport of peroxisomes in neurites [28, 38].”
BackgroundThe Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review
Nixon, R. A., Cataldo, A. M., & Mathews, P. M. (2000) · Neurochemical Research · doi:10.1023/a:1007675508413 · Cited by 318 · cited 1×
“Agebased metabolic changes may lead to an imbalance of metabolites and/or second messengers promoting mitochondrial, endosomal–lysosomal and peroxisomal dysfunctions, which might be involved in the initiation of neuropathological events in AD [26, 32].”
BackgroundBrain Membrane Phospholipid Alterations in Alzheimer's Disease
Pettegrew, J. W., Panchalingam, K., Hamilton, R. L., & McClure, R. J. (2001) · Neurochemical Research · doi:10.1023/a:1011603916962 · Cited by 292 · cited 4×
“both gray and white matter of AD patients [15, 18, 19, 34].”
BackgroundResultInfluentialReactive oxygen species and peroxisomes: Struggling for balance
Bonekamp, N. A., Völkl, A., Fahimi, H. D., & Schrader, M. (2009) · BioFactors · doi:10.1002/biof.48 · Cited by 274 · cited 1×
“Peroxisomes are present in all nucleated human cells, including all cell types of the brain, and perform anabolic and catabolic functions and play a major role in generation and decomposition of ROS, reviewed in [1, 6, 36, 41].”
BackgroundGoodenowe, D. B., Cook, L. L., Liu, J., Lu, Y., Jayasinghe, D. A., Ahiahonu, P. W. K., Heath, D., Yamazaki, Y., Flax, J., Krenitsky, K. F., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p700023-jlr200 · Cited by 252
Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain
Ginsberg, L., Rafique, S., Xuereb, J. H., Rapoport, S. I., & Gershfeld, N. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00931-f · Cited by 247
Peroxisomes Are Oxidative Organelles
Antonenkov, V. D., Grunau, S., Ohlmeier, S., & Hiltunen, J. K. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2996 · Cited by 221 · cited 1×
“Peroxisomes are present in all nucleated human cells, including all cell types of the brain, and perform anabolic and catabolic functions and play a major role in generation and decomposition of ROS, reviewed in [1, 6, 36, 41].”
BackgroundOxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis
Reddy, J. K., & Rao, M. S. (1989) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(89)90198-x · Cited by 193 · cited 1×
“It has also been reported that peroxisomal proliferation enhances oxidative stress [35].”
BackgroundMartinez, M. (1992) · Brain Research · doi:10.1016/s0006-8993(10)80021-6 · Cited by 190 · cited 1×
“esis deficiency (Zellweger syndrome spectrum) [30] and in AD [15, 18, 19, 29, 34].”
BackgroundHan, X. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772786 · Cited by 183 · cited 2×
“In myelin, mainly saturated and mono-unsaturated fatty acids have been found at the sn-2 position of plasmalogens, whereas in neurons predominantly PUFAs occupy this position [17].”
BackgroundHan, X. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.010 · Cited by 164 · cited 3×
“both gray and white matter of AD patients [15, 18, 19, 34].”
BackgroundResultWood, P. L., Mankidy, R., Ritchie, S., Heath, D., Wood, J. A., Flax, J., & Goodenowe, D. B. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.090059 · Cited by 162 · cited 2×
“Moreover, the level of circulating ethanolamine–plasmalogens is significantly decreased in serum from clinically and pathologically diagnosed AD subjects at all stages of dementia, and the severity of this decrease correlated with the severity of dementia [16, 42].”
BackgroundResultIdentification of three forms of human myelin basic protein by cDNA cloning.
Kamholz, J., de Ferra, F., Puckett, C., & Lazzarini, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4962 · Cited by 161
Biochemical aspects of X-linked adrenoleukodystrophy
Kemp, S., & Wanders, R. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00391.x · Cited by 116 · cited 1×
“In tissues of patients with the peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), both metabolic pathways contribute to the accumulation of VLCFA [22].”
BackgroundSelf-citationVreken, P., van Lint, A. E. M., Bootsma, A. H., Overmars, H., Wanders, R. J. A., & Gennip, A. H. (1998) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00186-8 · Cited by 99 · cited 1×
“VLCFA, pristanic acid and phytanic acid were measured according to previously described methods [40] and plasmalogens and PUFA as described in [13].”
MethodSelf-citationProbing HIV-1 Membrane Liquid Order by Laurdan Staining Reveals Producer Cell-dependent Differences
Lorizate, M., Brügger, B., Akiyama, H., Glass, B., Müller, B., Anderluh, G., Wieland, F. T., & Kräusslich, H.-G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.029256 · Cited by 86
Self-citationCimini, A., Moreno, S., D’Amelio, M., Cristiano, L., D’Angelo, B., Falone, S., Benedetti, E., Carrara, P., Fanelli, F., Cecconi, F., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1199 · Cited by 82 · cited 1×
“An altered intra-peroxisomal balance between ROS production by many oxidases and scavenging of ROS possibly adds to oxidative stress in AD, as recently suggested from animal studies [11].”
BackgroundKovács, G. G., Gelpi, E., Ströbel, T., Ricken, G., Nyengaard, J. R., Bernheimer, H., & Budka, H. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318093ecc7 · Cited by 79 · cited 1×
“This method is also described in [23].”
Self-citationEvidence that Plasmalogen is Protective Against Oxidative Stress in the Rat Brain
Kuczynski, B., & Reo, N. V. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9061-7 · Cited by 74 · cited 1×
“In addition, peroxisomes are required for some steps in the synthesis of several lipids with antioxidant properties and are thus involved in the cellular protection against ROS burden; prominent representatives are plasmalogens [24] and docosahexaenoic acid (DHA) [10].”
BackgroundAssay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts
Dacremont, G., & Vincent, G. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711431 · Cited by 71 · cited 1×
“VLCFA, pristanic acid and phytanic acid were measured according to previously described methods [40] and plasmalogens and PUFA as described in [13].”
MethodVienna Transdanube Aging “VITA”: study design, recruitment strategies and level of participation
Fischer, P. A., Jungwirth, S., Krampla, W. W., Weissgram, S., Kirchmeyr, W., Schreiber, W., Huber, K., Rainer, M., Bauer, P., & Tragl, K. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_11 · Cited by 70 · cited 1×
“To this end, we combined neuropathological, biochemical, lipidomic and immunohistochemical analyses focusing on peroxisomes in well-defined autopsy material derived from the Vienna Transdanube Aging (VITA) study, a longitudinal, community-based cohort study [14], enabling us to generate a uniform sample set of age-mat…”
MethodSelf-citationPurification of immunologically active recombinant 21.5 kDa isoform of human myelin basic protein
Nye, S. H., Pelfrey, C. M., Burkwit, J. J., Voskuhl, R. R., Lenardo, M. J., & Mueller, J. P. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00066-6 · Cited by 29 · cited 1×
“Isoform 5 is the most abundant form in the adult human CNS [33]; isoform 6 is identical to isoform 5 except for an 11 amino acid deletion near the C-terminus [21].”
BackgroundOrganotin compounds in trimethyltin-treated rats and in human brain in Alzheimer's Disease
Martin, F., Corrigan, F., Donard, O., Kelly, J., Besson, J., & Horrobin, D. (1997) · Human and Experimental Toxicology · doi:10.1177/096032719701600906 · Cited by 13 · cited 2×
“DHA incorporated into phospholipids and cholesterol esters were found to be reduced in brain [29] and plasma [12] of AD patients and several studies indicate a decreased risk for AD after an x3 (in particular DHA) rich diet [3, 20, 31].”
Background
Cited by
Functions of plasmalogen lipids in health and disease
Braverman, N. E., & Moser, A. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.008 · Cited by 1,082
“This correlates to the observed increase in lipid remodeling, as well as reduced levels of DHA and AA in brain plasmalogen fractions [84,87].”
BackgroundLipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
Using Whole-Exome Sequencing to Identify Inherited Causes of Autism
Yu, T. W., Chahrour, M. H., Coulter, M. E., Jiralerspong, S., Okamura-Ikeda, K., Ataman, B., Schmitz-Abe, K., Harmin, D. A., Adli, M., Malik, A. N., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.002 · Cited by 442
“PEX7 regulates peroxisomal protein import, and peroxisomes are abundant in dendrites (Kou et al., 2011).”
BackgroundYin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441
The peroxisome: an update on mysteries 2.0
Islinger, M., Voelkl, A., Fahimi, H. D., & Schrader, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1722-5 · Cited by 283
Metadata
- Authors
- Kou, J., Kovacs, G. G., Höftberger, R., Kulik, W., Brodde, A., Forss-Petter, S., Hönigschnabl, S., Gleiss, A., Brügger, B., Wanders, R., Just, W., Budka, H., Jungwirth, S., Fischer, P., & Berger, J.
- Affiliations
- Medical University of Vienna (AT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Heidelberg University (DE)
- Ludwig Boltzmann Institute for Age Research (AT)
- Corresponding author
- Berger, Johannes
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2011-05-19
- Volume
- 122
- Issue
- 3
- Pages
- 271-283
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC3168371
- OpenAlex
- W2124956869
- Cited by
- 227
- References
- 42
- Citations by year
- 2026: 7 · 2025: 21 · 2024: 12 · 2023: 20 · 2022: 22 · 2021: 17 · 2020: 25 · 2019: 13 · 2018: 9 · 2017: 12 · 2016: 10 · 2015: 17 · 2014: 19 · 2013: 10 · 2012: 12
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UvA-DARE (University of Amsterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- European Commission (LSHG-CT-2004-512018)
- Austrian Science Fund (P 21950)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- Alzheimer's disease, peroxisomes, peroxisomal dysfunction, very long chain fatty acids, plasmalogens, peroxisomal beta-oxidation, neurofibrillary tangles, neuritic plaques, Braak staging, tau phosphorylation, neuronal soma
- MeSH terms
- Aged, 80 and over, Alzheimer Disease, Brain, Double-Blind Method, Fatty Acids, Female, Humans, Male, Myelin Sheath, Plasmalogens, Postmortem Changes, Cohort Studies, Neurofibrillary Tangles, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.